|
|
TTD Drug ID:
DNC003901
Drug
Information |
Name | CI-930 | Synonyms | CI-930 | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C14H14N4O/c1-10-8-13(19)16-17-14(10)11-2-4-12(5-3-11)18-7-6-15 -9-18/h2-7,9-10H,8H2,1H3,(H,16,19) | InChIKey | AEZZPAQOEUQNBB-UHFFFAOYSA-N | Canonical SMILES | CC1CC(=O)NN=C1C2=CC=C(C=C2)N3C=CN=C3 | Target | Phosphodiesterase 3A |  | Inhibitor | [1] | Ref 1 | J Med Chem. 1989 Feb;32(2):342-50.Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|